
Quanterix Corporation QTRX
$ 3.4
-5.56%
Annual report 2025
added 03-02-2026
Quanterix Corporation Operating Expenses 2011-2026 | QTRX
Annual Operating Expenses Quanterix Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 191 M | 136 M | 120 M | 149 M | 120 M | 79.8 M | 68.4 M | 49.5 M | 36 M | 29.5 M | 20.2 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 191 M | 20.2 M | 90.8 M |
Quarterly Operating Expenses Quanterix Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.5 M | 48.4 M | 42.8 M | - | 31.9 M | 33.2 M | 33.7 M | - | 28.7 M | 26.3 M | - | 47.5 M | 33.7 M | 32.7 M | - | 30.5 M | 27.5 M | 26.1 M | - | 18.8 M | 17.4 M | 18.5 M | - | 17.3 M | 17.4 M | 15.4 M | - | 13.3 M | 11.3 M | 10.3 M | - | 8.95 M | 11.7 M | 11.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.5 M | 8.95 M | 25.7 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Bruker Corporation
BRKR
|
1.4 B | - | - | $ 5.81 K | ||
|
Align Technology
ALGN
|
2.19 B | $ 185.02 | -0.81 % | $ 13.9 B | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.58 | -0.55 % | $ 1.7 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.61 | 3.18 % | $ 38 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.59 | 1.99 % | $ 134 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.8 | -7.2 % | $ 69.4 M | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 63.42 | -1.84 % | $ 93.9 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.5 | 0.38 % | $ 297 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
40.3 M | $ 25.39 | -1.24 % | $ 215 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.68 | -2.19 % | $ 7.43 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 338.38 | -0.87 % | $ 129 B | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.53 | -7.39 % | $ 388 M | ||
|
Tactile Systems Technology
TCMD
|
221 M | $ 25.13 | -0.87 % | $ 575 M | ||
|
Globus Medical
GMED
|
547 M | $ 92.76 | -1.89 % | $ 12.5 B | ||
|
TELA Bio
TELA
|
88.1 M | $ 0.73 | 11.88 % | $ 34.3 M | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.06 | 6.19 % | $ 1.25 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 5.29 | 8.74 % | $ 1.12 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Tandem Diabetes Care
TNDM
|
159 M | $ 20.09 | -2.76 % | $ 1.37 B | ||
|
Inogen
INGN
|
184 M | $ 6.59 | 6.29 % | $ 175 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | - | $ 17.6 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.83 | -1.46 % | $ 388 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 56.45 | -0.34 % | $ 1.66 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 37.91 | -3.88 % | $ 1.18 B | ||
|
LivaNova PLC
LIVN
|
697 M | $ 65.01 | -0.2 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | $ 88.37 | 0.49 % | $ 3.07 B |